Decoding leukemia-immune cell dynamics by organism-wide cellular interaction mapping

Develop a novel 'interact-omics' approach to analyze cellular interactions in leukemia, aiming to enhance understanding of immune responses and therapy resistance mechanisms.

Subsidie
€ 1.499.596
2023

Projectdetails

Introduction

Cellular interactions are of fundamental importance in life, orchestrating organismal development, tissue homeostasis, and immunity. In the immune system, cell-cell interactions act as central hubs for information processing and decision making that collectively determine the outcome of complex immune responses.

Importance in Leukemias

In leukemias, a cancer originating from immature immune cells, a multilayered network of cellular interactions between immune and leukemic cells underlies effective immune control of the cancer, immune evasion, and response to immunotherapies.

Technical Limitations

However, technical limitations in studying cell-cell interactions restrict our understanding of these highly complex and dynamic processes.

Proposed Solution

In order to overcome this limitation, I propose to develop a novel ‘interact-omics’ approach, capable of characterizing millions of cellular interactions across complex organ systems, entire organisms, and patient cohorts.

Application of the Approach

Applying the ‘interact-omics’ approach to sophisticated leukemia mouse models will enable us to dissect the dynamic cellular interaction networks between:

  1. Antigen-specific T cells
  2. Bystander immune cells
  3. Leukemic cells

These interactions drive anti-leukemia immunity and immune evasion.

In Vivo Perturbation

In combination with the in vivo perturbation of cellular interactions, this will allow us to systematically decode the cellular logic of how the complex leukemia-immune interplay determines the disease course.

Understanding Therapy Resistance

Additionally, by making use of leukemia patient cohorts that are either responsive or non-responsive to immunotherapy treatment, we will unravel previously unknown therapy resistance mechanisms and predict therapy response.

Conclusion

Together, our approach will set the basis for a comprehensive understanding of the leukemia-immune cell crosstalk underlying immune control, immune escape, and therapy response. It may serve as a blueprint to fundamentally expand our insights into other biological processes driven by cellular interactions.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.499.596
Totale projectbegroting€ 1.499.596

Tijdlijn

Startdatum1-2-2023
Einddatum31-1-2028
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • CHARITE - UNIVERSITAETSMEDIZIN BERLINpenvoerder

Land(en)

Germany

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860

Vergelijkbare projecten uit andere regelingen

ERC COG

Mechanistic models of leukemia-niche interaction using multimodal single cell profiling

This project aims to uncover AML's interactions with the bone marrow niche through advanced single-cell sequencing and modeling, potentially transforming treatment strategies for hematological malignancies.

€ 2.000.000
ERC COG

Elucidating the Spatial and Temporal Dynamics of Acute Myeloid Leukemia Progression Using Functional Omics and High-Throughput In Vivo Screening

This project aims to explore the spatial and temporal dynamics of tumor progression in Acute Myeloid Leukemia to identify critical factors influencing cancer pathogenicity and potential therapeutic targets.

€ 1.994.500